Search clinical trials for: Guselkumab Dose 2
Total 21241 results
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Janssen Research & Development, LLCActive, not recruitingCrohn's DiseaseUnited States, Israel, Japan, Belgium, Lebanon, Taiwan, Netherlands, Russian Federation, Korea, Republic of, Jordan, France, Portugal, Turkey, Greece, Canada, Germany, Malaysia, Belarus, Latvia, Poland, Australia, Italy, Croatia, Hungary and more
-
Janssen Research & Development, LLCActive, not recruitingColitis, UlcerativeFrance, United States, Jordan, Taiwan, Turkey, Canada, Germany, Malaysia, New Zealand, Korea, Republic of, Hungary, Poland, Australia, Belgium, Japan, China, Czechia, Israel, India, Brazil, Spain, Argentina, Slovakia, Bulgaria, Mexico
-
Janssen Research & Development, LLCActive, not recruitingCrohn DiseaseBelgium, United States, Japan, Czechia, Hungary, Korea, Republic of, France, Taiwan, Germany, Malaysia, New Zealand, Poland, Canada, Turkey, Croatia, Israel, China, Denmark, Netherlands, Brazil, Italy, Spain, Jordan, Bosnia and Herzegovina and more
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompletedHidradenitis SuppurativaUnited States, France, Canada, Germany, Netherlands, Denmark
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Janssen Research & Development, LLCCompletedColitis, UlcerativeUnited States, Russian Federation, Australia, Poland, Germany, Brazil, Ukraine, Argentina, Mexico
-
Institute of Medical Biology, Chinese Academy of...Guangxi Center for Disease Control and PreventionCompleted
-
Janssen Research & Development, LLCTerminatedLupus NephritisUnited States, Taiwan, Mexico, Spain, Russian Federation, Thailand, Poland, Argentina, Ukraine
-
Rutgers, The State University of New JerseyCenters for Disease Control and PreventionCompletedViolence | Helping Behavior | Sexual Assault and Rape | Assaultive BehaviorUnited States
-
University of MinnesotaRecruitingSolid Organ TransplantUnited States
-
PfizerCompletedFungal InfectionNetherlands
-
Taiho Pharmaceutical Co., Ltd.Recruiting
-
University of California, San FranciscoJanssen Scientific Affairs, LLCRecruiting
-
University of California, San FranciscoJanssen Biotech, Inc.Recruiting
-
Janssen-Cilag Ltd.TerminatedPsoriasisItaly, Germany, Greece
-
Medy-ToxCompletedLateral Canthal Lines | Glabellar LinesUnited States, Russian Federation, Germany, Canada, Belgium, United Kingdom
-
Sanofi Pasteur, a Sanofi CompanyCompletedInfluenza | FluChina
-
University Medical Center GroningenJanssen-Cilag Ltd.CompletedHidradenitis SuppurativaNetherlands
-
Janssen-Cilag S.p.A.Completed
-
Janssen Research & Development, LLCNo longer availableAdenomatous Polyposis Coli
-
Janssen Research & Development, LLCCompleted
-
AblynxCompletedHealthy VolunteersUnited States
-
Janssen Research & Development, LLCCompletedHealthyUnited States, Germany
-
Janssen Pharmaceutical K.K.Completed
-
Loyola UniversityNational Cancer Institute (NCI)Active, not recruiting
-
Janssen Research & Development, LLCCompleted
-
Aronora, Inc.CompletedThrombosis | End Stage Renal DiseaseUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedLeukemia | Leukemia, B-Cell, ChronicUnited States
-
NYU Langone HealthJanssen Scientific Affairs, LLCRecruiting
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Janssen Research & Development, LLCActive, not recruitingA Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis (QUASAR)Ulcerative ColitisUnited States, Belgium, Netherlands, Japan, United Kingdom, France, Korea, Republic of, Taiwan, Jordan, Turkey, Canada, Israel, Germany, Malaysia, Hungary, Ireland, Latvia, Bulgaria, Poland, Australia, Italy, China, Spain, Czechia, Russian... and more
-
Acerus Pharmaceuticals CorporationCompletedFemale Orgasmic DisorderUnited States, Canada, Australia
-
Janssen Research & Development, LLCWithdrawn
-
Pharnext SACompletedPhase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) (PLEO-CMT)Charcot-Marie-Tooth Disease Type 1AUnited States, United Kingdom, Belgium, Canada, France, Netherlands, Spain, Germany
-
Janssen Research & Development, LLCActive, not recruitingPlaque Psoriasis | Scalp PsoriasisUnited States, Canada
-
Virginia Commonwealth UniversityGilead SciencesWithdrawnChronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL | Refractory Small Lymphocytic Lymphoma | SLL | Relapsed CLL | Relapsed Chronic Lymphocytic Leukemia | Relapsed Small Lymphocytic Lymphoma
-
Novartis PharmaceuticalsCompletedSchizophrenia DisordersUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
University of VermontInternational Centre for Diarrhoeal Disease Research, Bangladesh; Thrasher... and other collaboratorsCompletedRotavirus Infection | Vaccine Response Impaired | Vaccine Virus SheddingBangladesh
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCActive, not recruitingCrohn's DiseaseUnited States, Poland
-
Janssen Research & Development, LLCCompletedAdenomatous Polyposis ColiUnited States, Germany, France, Israel, Netherlands, Poland, Puerto Rico, Spain, Sweden
-
Centre Hospitalier Universitaire de Saint EtienneSanofi Pasteur, a Sanofi Company; Bioster, a.s.Completed
-
Sparrow PharmaceuticalsRecruitingAutonomous Cortisol Secretion (ACS) | ACTH-Independent Cushing Syndrome | ACTH-Independent Adrenal Cushing Syndrome, SomaticUnited States, United Kingdom, France, Romania
-
Galapagos NVCompletedCystic FibrosisBelgium, Netherlands
-
Galapagos NVCompletedCystic FibrosisUnited Kingdom, Australia, Ireland, Germany, Czech Republic